MLL1 fusions have been shown to recruit DOT1L, a histone 3 lysine 79 (H3K79) methyltransferase and epigenetic marker of leukemic stem cells which has been implicated in the development of leukemia (Bernt et al., 2011). This evidence concerns the gene DOT1L and leukemia.